Prescription
Patient & assumptions
Projected systemic citrate
Numbers, equations and clinical pearls
| Liver clearance | 2 h | 4 h | 6 h | Steady state | 95% of SS |
|---|
CMax = [QACDA·CACDA ÷ plasma flow] × (1 − Ecit) ÷ Ecit · C(t) = C(0)e−Kt/V + G/K·(1 − e−Kt/V), K = Kf + Kb
- Accumulation is a prescription problem first. CMax depends only on the ACD-A : QB ratio, hematocrit and Ecit.
- Shock settings. Lower QB with high effluent pushes Ecit above ~0.75 and keeps CMax under ~2.5 even with no liver metabolism.
- Edema changes speed, not the plateau.
Model notes: Single-pool, fixed-volume kinetic equation (Szamosfalvi et al.; validated by Zheng), as applied in Yessayan et al., BMC Nephrology 2021. Ecit is estimated as clearance-effective effluent (QD × SD + QRF + net UF + QACDA) ÷ (plasma flow + ACD-A flow), assuming citrate sieving ≈ 1 and post-dilution replacement; QRF is zero in CVVHD. Real extraction is lower with filter clotting or unsaturated dialysate. Hct ≈ Hb × 3. Calcium infusion volume and citrate–calcium complex losses are ignored. Defaults reproduce the paper’s non-shock example (QB 150 mL/min, ACD-A 300 mL/h, QD/QRF 1.2 L/h, net UF 0.2 L/h, Hb 7.5 g/dL, ECF 15 L + 7 L edema).
Clinical disclaimer — read before using
DISCLAIMER: The authors make no claim of the accuracy of the information contained herein. The calculations suggested above are inherently prone to errors and bias, and should not be a substitute for clinical judgement. The authors involved in the preparation of the site and its content should not be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER PRIOR TO USING THE SITE. BY ACCESSING AND USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS OF THE DISCLAIMER.